The hyperleptinemia that occurs in MetS induces the production of ROS such as H2O2 and OH radicals, decreases the activity of cellular PON-1, and leads to increased plasma levels of MDA and hydroperoxides [59]. Here, PON1 is linked to metabolic syndrome.